Use of erythropoietin in the treatment of rheumatoid arthritis

Details Use of erythropoietin in the treatment of rheumatoid arthritis Use of erythropoietin in the treatment of rheumatoid arthritis

2008-03-18

2008-03-18

Ewoldt, G. R. (Department: 1644)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C424S198100

Reexamination Certificate

active

07344717

ABSTRACT:
A novel use of the known protein Erythropoietin (EPO) and/or a derivative and/or a fragment thereof is disclosed. EPO is used as a pharmaceutical for the treatment of chronic inflammations. A particularly beneficial result is seen in patients suffering from rheumatoid arthritis (RA). Significant effects are seen in clinical variables such as morning stiffness, swollen joints, and the like.

REFERENCES:
patent: 0 269 394 (1988-06-01), None
patent: 2 171 304 (1986-08-01), None
patent: 2171304 (1986-08-01), None
Robbins Pathological Basis of Disease, 4th edition, pp. 190-193, 1989.
Smilek, D et al., PNAS 88:9633-37, A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce EAE, Nov. 1991.
Toshihide, S et al. Kyushu Riumachi (Kyushu Journal of Rheumatology, 1991, 10(1):19-23. English Abstract Only.
Petterson, T et al. Scandinavian Journal of Rheumatology, 1993, 22 (4):188-193.
Swaak et al. Clin. Exp. Rheumatol, p. 577, 1994.
Chemical Abstracts, vol. 101, No. 3, Jul. 16, 1994, Biemond et al., “Iron Mobilization From Ferritin by Superoxide Derived From Stimulated Polymorphonuclear . . . ”.
Annals of Hematology, vo. 65, No. 6, Dec. 1992, pp. 265-268, G. Vreugdenhil et al, “Iron Stores and Serum Transferrin Receptor Levels During Recombinant Human Erythropoietin . . . ”.
Arthrits & Rheumatism, vol. 38, No. 9, Sep. 1995, p. S288, H.R.M. Peeters et al., “Effect of Recombinant-Human Erythropoietin on Anaemia and Disease Activity in Patients . . . ”.

Affiliated with

Also associated with

Rating

Use of erythropoietin in the treatment of rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of erythropoietin in the treatment of rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of erythropoietin in the treatment of rheumatoid arthritis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2812623